A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing

被引：4

作者：

Kim, Jennifer S. ^{[1
]}

Wood, Robert A. ^{[2
]}

Lindblad, Robert ^{[3
]}

Noone, Sally A. ^{[1
]}

Paterakis, Melissa N. ^{[2
]}

Henning, Alice ^{[3
]}

Nadeau, Kari C. ^{[4
]}

Spann, Kyrsten ^{[4
]}

Sampson, Hugh A. ^{[1
]}

机构：

[1] Mt Sinai, Icahn Sch Med, New York, NY USA

[2] Johns Hopkins Univ, Med Ctr, Baltimore, MD 21218 USA

[3] EMMES Corp, Rockville, MD USA

[4] Stanford Univ, Stanford, CA 94305 USA

来源：

关键词：

D O I：

10.1016/j.jaci.2013.12.1067

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

L19

引用

页码：AB403 / AB403

页数：1